drugset / Trial / NCT00442364
Safety Study of Varisolve® Procedure for Treatment of Varicose Veins in Patients With Right-to-left Cardiac Shunt
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the safety of the Varisolve® procedure in patients with right-to-left cardiac shunt (a defect in the heart).
Timeline
- Start
- 2007-03
- Primary completion
- 2008-06
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Polidocanol | Other / unclassified | 1 % | Intravenous |
| Subject | Polidocanol | Other / unclassified | 20 ml | Intravenous |